Artiva Biotherapeutics, Inc. (ARTV)
3.07
-0.05
(-1.60%)
USD |
NASDAQ |
Dec 10, 16:00
3.02
-0.05
(-1.63%)
After-Hours: 20:00
Artiva Biotherapeutics Enterprise Value: -36.48M for Dec. 10, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Ovid Therapeutics, Inc. | 103.52M |
| Kezar Life Sciences, Inc. | -33.80M |
| Olema Pharmaceuticals, Inc. | 1.782B |
| Disc Medicine, Inc. | 2.920B |
| NovaBay Pharmaceuticals, Inc. | 307.92M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.53M |
| Total Expenses (Quarterly) | 21.53M |
| EPS Diluted (Quarterly) | -0.8794 |
| Earnings Yield | -105.8% |
| Normalized Earnings Yield | -105.80 |